Oxycodone drugs market to reach $8.07 billion by 2030 at 6.1% cagr, driven by rising burden of orthopedic disorders and chronic pain conditions.
Read MoreThe nocturnal leg cramps treatment market is projected to reach $3.22 billion by 2030, growing at 6.4% CAGR, driven by personalized care, non-drug therapies, and self-care solutions.
Read MoreOvulation inducing drugs market to reach $6.62 billion by 2030 at 7.3% cagr, driven by increasing prevalence of women’s infertility globally.
Read MoreGlobal Nocturia market size is expected to reach $4.51 billion by 2030 at 7.7%, impact of cardiovascular disease prevalence on the growth of the market
Read MoreOver the counter vitamins and minerals dietary supplements market to reach $73.4 billion by 2030 at 6.1% cagr, driven by growing awareness of preventive healthcare.
Read MoreGlobal Night Blindness Treatment market size is expected to reach $5.66 billion by 2030 at 6.1%, segmented as by medication, vitamin a supplements, retinoid therapy, beta-carotene supplements, anti-glaucoma medications
Read MoreOver the counter sleep aids medication market to reach $33.15 billion by 2030 at 7.8% cagr, driven by rising prevalence of insomnia and growing stress levels.
Read MoreGlobal Niemann-Pick Disease Type C Treatment market size is expected to reach $4.46 billion by 2030 at 8.8%, rising prevalence of alzheimer’s disease fueling the growth of the market due to shared neurodegenerative research
Read MoreOver the counter probiotics supplements market to reach $12.1 billion by 2030 at 11.0% cagr, driven by increasing prevalence of digestive disorders worldwide.
Read MoreGlobal Niemann-Pick Disease (NPD) market size is expected to reach $1.79 billion by 2030 at 10.8%, the growing adoption of gene therapy driving the market growth by addressing genetic mutations and enhancing treatment outcomes
Read More